Major League Baseball and UCLA will examine the growth of HGH in sports come next month.
Major League Baseball and the law firm Foley & Lardner LLP have partnered with the Office of Continuing Medical Education at the David Geffen School of Medicine at the University of California at Los Angeles to conduct a Growth Hormone Summit on Monday, Nov. 10th, Baseball Commissioner Allan H. (Bud) Selig announced today.
The world's leading anti-doping experts and scholars will convene in Beverly Hills, California for the summit and will be chaired by Dr. Gary Green, Clinical Professor in the Division of Sports Medicine at the David Geffen School of Medicine at UCLA and Major League Baseball's consultant on Performance Enhancing Drugs. Entitled "Growth Hormone: Barriers to Implementation of hGH Testing in Sports," the summit will attempt to identify the scientific, medical, legal and ethical issues that must be addressed before Human Growth Hormone testing can be considered a routine part of sports drug testing.
The educational objectives of the comprehensive program will focus on understanding the currently available methods for identifying use of hGH and understanding the viability of urine testing for hGH in the future; building a consensus on the most effective methods of implementing widespread blood testing for abuse of hGH; identifying future strategies for hGH testing; and understanding the United States Laws regarding the regulation and distribution of hGH.
"After the Mitchell report, one of my main goals was to bring together the leading anti-doping experts for an hGH summit," said Commissioner Selig. "The effective regulation of hGH remains one of the foremost challenges for anti-doping efforts in all sports. This summit is a significant step forward, and Major League Baseball is pleased that Dr. Green, one of the foremost experts in the field, will head this initiative."
Here is the All-Star cast:
Moutian Wu, PhD, who served as the Laboratory Director for the 2008 Beijing Olympics and who currently works with the National Anti-Doping Laboratory and the China Anti-Doping Agency, will be one of the principal speakers at the summit. Other summit presentations and panel discussants will feature Anthony W. Butch, PhD, Director of the UCLA Olympic Analytical Laboratory; Don H. Catlin, MD, Director, Anti-Doping Research; Alan Goldhammer, PhD, Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America; Richard I.G. Holt, MD, PhD, Professor in Diabetes & Endocrinology in the School of Medicine at the University of Southampton; Lance Liotta, MD, PhD, Co-Director, Center for Applied Proteomics & Molecular Medicine at George Mason University; Robert D. Manfred, Jr., Major League Baseball Executive Vice President for Labor Relations & Human Resources; Matthew J. Mitten, Professor of Law and Director of the National Sports Law Institute at Marquette University Law School; Thomas H. Murray, PhD, President & CEO, The Hastings Center; Thomas T. Perls, MD, MPH, FACP, Director of the New England Centenarian Study; Douglas E. Rollins, MD, PhD, Executive Director, Sports Medicine Research and Testing Laboratory; Travis T. Tygart, CEO of the United States Anti-Doping Agency; and Frank D. Uryasz, President of The National Center for Drug Free Sport.
Maybe someone can explain why MLB never punished baseball players who reportedly ordered HGH form the Florida Internet pharmacies. Track suspended athletes with 'nonanalytic positives', but baseball doesn't (uinless a player is in the minor leagues)